Metformin is not only the first-line medication for the treatment of type 2 diabetes, but it is also effective as an anti-inflammatory, anti-oxidative and anti-tumor agent. However, the effect of metformin during viral hepatitis remains elusive. Using an adenovirus (Ad)-induced viral hepatitis mouse model, we found that metformin treatment significantly attenuated liver injury, with reduced serum aspartate transaminase (AST) and alanine transaminase (ALT) levels and liver histological changes, presumably decreased effector T cell responses. We then demonstrated that metformin reduced mTORC1 activity in T cells from infected mice, as evidenced by decreased phosphorylation of ribosome protein S6 (p-S6). The inhibitory effects on the mTORC1 signaling by metformin was dependent on the tuberous sclerosis complex 1 (TSC1). Mechanistically, metformin treatment modulated the phosphorylation of dynamin-related protein 1 (Drp-1) and mitochondrial fission 1 protein (FIS1), resulting in increased mass in effector T cells. Moreover, metformin treatment promoted mitochondrial superoxide production, which can inhibit excessive T cell activation in viral hepatitis. Together, our results revealed a protective role and therapeutic potential of metformin against liver injury in acute viral hepatitis modulating effector T cell activation regulating the mTORC1 pathway and mitochondrial functions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097169PMC
http://dx.doi.org/10.3389/fimmu.2021.638575DOI Listing

Publication Analysis

Top Keywords

viral hepatitis
20
liver injury
12
metformin treatment
12
metformin
9
effector cell
8
cell activation
8
viral
5
hepatitis
5
metformin modulates
4
cell
4

Similar Publications

Article Synopsis
  • The report updates the 1999 CDC Framework for Program Evaluation in Public Health to include new advancements and lessons learned in evaluation and public health.
  • The 2024 framework introduces a nonprescriptive tool with six steps for effective evaluation planning and implementation, while emphasizing engagement, equity, and learning from insights.
  • It serves as a guide for designing evaluations applicable to various programs, enhancing evidence-based decision-making, and improving program outcomes across different areas.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!